News
How Deployable Field Hospitals Transform The Healthcare Landscape
With COVID-19 cases winding down to manageable numbers (though the virus is still a threat), some experts and parts of the general public can’t help but ask when the next pandemic will be. No one has a concrete answer,...
Drug Research
Cognizant, Boehringer Collaborate on Unified Cloud Platform to Speed Drug Development
Cognizant is working with Boehringer Ingelheim, a research-driven biopharmaceutical company, to advance the speed and quality of medicinal therapy development. Leveraging the Veeva Development Cloud, Cognizant will help Boehringer Ingelheim to unify medicinal development processes and data into a...
News
Merck & XtalPi Collaboration Optimizes Drug Formulations with AI-Powered Techniques
Science and technology company Merck and XtalPi Inc., a pioneering pharmaceutical technology company powered by artificial intelligence (AI) and automation, have jointly published a study that highlights the benefits of combining computational workflows with wet lab experiments to advance...
Clinical Trials
Angle PLC, Crescendo Biologics Ink Clinical Services Contract
ANGLE plc, one of the world-leading liquid biopsy companies, is delighted to announce that it has signed a contract with a new customer, Crescendo Biologics Limited (Crescendo). Crescendo is a UK-based, clinical stage immuno-oncology company with an extensive proprietary...
Drug Research
Wheeler Bio $31M in Financing to Support Clinical Drug Substance Mfg. Facility
Wheeler Bio, Inc., a CDMO specializing in process development and small batch cGMP production of therapeutic antibodies, announced the closing of their Series A financing round. The company will use the funding to complete its state-of-the-art cGMP cell banking...
Drug Research
Araris Biotech AG Announces Strategic Investment with Samsung Ventures
Araris Biotech AG, a company pioneering a proprietary antibody-drug conjugate (ADC)-linker technology,announced that Samsung Venture Investment Corporation (“Samsung Ventures”), an investment corporation established to promote the development of new technologies, has invested in the Company in an independent deal...
Drug Research
CBM Completes Tech Transfer for Manufacturing Platform for AAV Production
The Center for Breakthrough Medicines (CBM), a contract development and manufacturing organization (CDMO) dedicated to addressing critical challenges associated with the commercialization of cell and gene therapies, has completed a successful technology transfer of the University of Pennsylvania Gene...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.
Must read